Related Experiment Video
Updated: Sep 16, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
The dawn of in silico clinical trials in cardiovascular diseases: Lessons from the SIRIUS programme
Denis Angoulvant1, Jean-Pierre Boissel2
1Cardiology Department, Hôpital Trousseau, CHRU de Tours, UMR Inserm 1327 ISCHEMIA "Membrane Signaling and Inflammation in Reperfusion Injuries", Université de Tours, 37000 Tours, France.
No abstract available in PubMed .
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Preclinical Development: Overview
Coronary Artery Disease IV: Preventive Measures